bioRxiv · 10.1101/2025.06.02.657359
GENOTYPIC DETECTION OF ANTIBIOTIC-RESISTANT GENES IN EMERGING BACTERIAL PATHOGENS FROM NEONATAL SEPSIS PATIENTS IN LAGOS
Abstract
High-risk neonatal sepsis resulting in up to four million infants mortality and organ damages during the first 28 days of life predominates in low-income countries. We investigated genotypic antibiotic-resistant genes in emerging bacterial pathogens from newborn sepsis cases in Lagos. A cross-sectional study of 294 at-risk hospitalised newborns in prominent paediatrics hospitals throughout three senatorial districts of Lagos utilised the socio-demographic data of their mothers and informed consents. We aseptically collected approximately 3 mL of venous blood from neonates, subsequently isolated and identified the associated bacteria using agar culture on Mueller Hinton agar. To evaluate the antibiotic resistance genes, we used Kirby-Bauer disc diffusion technique; MICROBACTTM Identification System and molecular techniques including PCR, RAPD-PCR, sequencing and docking. From 294 patient samples, 110 (37.4%) were cultured positive, with men (47%), females (53%), ages [≤] 72 hours (71.8%), and ages > 72 hours (28.1%). Klebsiella pneumoniae, K. oxytoca, Enterobacter gergoviae, Serratia rubidiae, Escherichia coli, and Cronobacter sakazakii were the involved Gram- negative bacteria, whereas Coagulase-negative Staphylococci, Staphylococcus aureus, and Enterococcus faecalis were the involved Gram-positive bacteria. Fourteen (12.7%) positive bacteria were resistant to only three antibiotic classes, whereas 73 (66.4%) were resistant to over three antibiotics. Antibiotic- resistant genes bla-CTX, bla-SHV, and bla-TEM were found in Serratia rubidiae and Enterobacter gergoviae, unusual aetiology of newborn sepsis. Molecular docking proved Meropenems antibacterial effectiveness. The identified antimicrobial-resistant genes are crucial for improved patient management, as high- resistance strains of ampicillin, gentamicin, and cefotaxime remain ineffective against bacterial sepsis, leaving Meropenem as the sole feasible therapeutic option.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Adegboyega, H. O., Banjo, T. A., Deji-Agboola, A. M., Iwalokun, B., Mutiu, W. B., Osinupebi, O. A., Shorunmu, T. O., Oladoja, F. A., Fatungase, O. M., Adeyanju, M. M., Akindele, R. A., Fakunle, P. B., Olabode, B. A., Ajayi, O. O., Onadeko, O., Oyelekan, A. A. A., Oritogun, K. S., Ariyibi, S. O., Omirin, E. S.. 2025-06-02. GENOTYPIC DETECTION OF ANTIBIOTIC-RESISTANT GENES IN EMERGING BACTERIAL PATHOGENS FROM NEONATAL SEPSIS PATIENTS IN LAGOS. https://doi.org/10.1101/2025.06.02.657359
Cite the original work for its findings. Save a collection to share your selection of sources.